UBS Group AG - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$398,244
-54.1%
92,186
-30.0%
0.00%
Q2 2023$867,936
-4.5%
131,705
-1.6%
0.00%
Q1 2023$909,256
-11.4%
133,911
-3.6%
0.00%
Q4 2022$1,026,456
+121.2%
138,898
+195.5%
0.00%
Q3 2022$464,000
-26.3%
47,003
-18.6%
0.00%
Q2 2022$630,000
-57.9%
57,743
-56.4%
0.00%
Q1 2022$1,498,000
+74.0%
132,486
+141.3%
0.00%
Q4 2021$861,000
+1.3%
54,908
+10.6%
0.00%
Q3 2021$850,000
+1365.5%
49,624
+1737.2%
0.00%
Q2 2021$58,000
-94.8%
2,701
-96.3%
0.00%
Q1 2021$1,108,000
+30.8%
73,764
+14.4%
0.00%
Q4 2020$847,000
+764.3%
64,490
+537.8%
0.00%
Q3 2020$98,000
-66.9%
10,111
-60.9%
0.00%
Q2 2020$296,000
+1038.5%
25,859
+912.1%
0.00%
Q1 2020$26,000
-97.9%
2,555
-96.6%
0.00%
Q4 2019$1,234,000
+17.1%
75,179
-5.3%
0.00%
Q3 2019$1,054,000
+1071.1%
79,388
+1151.8%
0.00%
Q2 2019$90,000
-29.1%
6,342
-8.6%
0.00%
Q1 2019$127,000
-97.1%
6,942
-95.9%
0.00%
-100.0%
Q4 2018$4,454,000
+660.1%
170,446
+567.4%
0.00%
Q3 2018$586,000
+205.2%
25,539
+153.4%
0.00%
Q2 2018$192,000
-86.6%
10,079
-88.1%
0.00%
-100.0%
Q1 2018$1,428,000
+50.8%
84,739
+35.9%
0.00%
Q4 2017$947,000
-65.7%
62,357
-59.5%
0.00%
-100.0%
Q3 2017$2,759,000
+1074.0%
154,105
+967.4%
0.00%
Q2 2017$235,000
+42.4%
14,438
+22.1%
0.00%
Q1 2017$165,000
-75.2%
11,820
-71.7%
0.00%
Q4 2016$666,000
+108.8%
41,698
+118.2%
0.00%
Q3 2016$319,000
-19.4%
19,112
-45.9%
0.00%
Q2 2016$396,000
+91.3%
35,349
+42.6%
0.00%
Q1 2016$207,000
-83.9%
24,786
-82.1%
0.00%
-100.0%
Q4 2015$1,288,000
+293.9%
138,346
+377.1%
0.00%
Q3 2015$327,000
-10.7%
29,000
+0.8%
0.00%
Q2 2015$366,000
-73.6%
28,778
-80.7%
0.00%
-100.0%
Q1 2015$1,388,000
+4106.1%
149,300
+6391.3%
0.00%
Q4 2014$33,0002,3000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders